Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Electromed Q1 2026 Results: Net Income $2.76M, Up 29.3% YoY

Electromed, Inc. reported net revenues of $18.7 million for the quarter ended September 30, 2026, a 10.6% increase over the prior year, driven primarily by growth in the homecare market. Net income rose to $2.8 million from $2.1 million, while the company significantly increased its common stock repurchases to $4.3 million during the period.

Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue18.716.9
Gross profit14.913.2
Profit before tax3.62.8
Net income2.82.1
EPS (diluted, $ a share)$0.32$0.25

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+29.3%
Revenue, year on year+10.6%
Gross margin80.0%
Operating margin18.7%
Source

10-Q filed with the SEC, NYSE: ELMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Electromed, Inc.: key numbers

Share price
$23.10Close, Nov 16
Market cap
$189M
Shares outstanding
8.17MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic ApparatusSIC 3845

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Electromed, Inc.

All →
4:08 PM ET 8-K
Financial Results

Electromed Financial Results

Electromed reported its 16th consecutive quarter of year-over-year revenue and operating income growth for the fiscal first quarter ended September 30, 2026. Net revenues increased 10.6% to $18.7 million, driven by strong performance in the core homecare market, while net income rose 29.3% to $2.8 million. The company remains debt-free and returned $4.3 million to shareholders through share repurchases during the quarter.

Term
Q1 2027

“We delivered our 16th consecutive quarter of year-over-year revenue and operating income growth, with double-digit revenue growth, a 30.7% increase in operating income and an 80.0% gross margin—demonstrating the strength of our direct-to-patient model and operating leverage. We also returned $4.3 million to shareholders through share repurchases while remaining debt-free. With a strong balance sheet and high-performing sales and fulfillment teams, Electromed is well positioned to bring SmartVest® therapy to more patients who need to breathe easier.”

Jim Cunniff, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.